Navigation Links
MedCath Announces Extension of Tolling Agreement With U.S. Department of Justice
Date:11/19/2012

CHARLOTTE, N.C., Nov. 19, 2012 /PRNewswire/ -- MedCath Corporation announced today that it has extended its Tolling Agreement with the U.S. Department of Justice (the "DOJ") until April 30, 2013. The Tolling Agreement, which expired October 31, 2012, tolls or suspends the statute of limitations for allegations related to the DOJ's industry-wide investigation of implantable cardioverter defibrillator ("ICD") implantations. The DOJ requested that MedCath extend the Tolling Agreement until April 30, 2013 as the DOJ continues its investigation of the hospital industry's compliance with Medicare coverage requirements for ICD procedures. MedCath continues to cooperate with the investigation.

About MedCath
MedCath Corporation, headquartered in Charlotte, N.C., was a health care provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. Having now divested all of its hospitals and filed for dissolution, MedCath is focused on realizing the value of its remaining immaterial assets, making tax and regulatory filings, winding down its business affairs, managing its known and unknown contingencies, and seeking to make distributions, if any, to its stockholders as part of its plan of dissolution.


'/>"/>
SOURCE MedCath Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Cord Blood America Announces 3rd Quarter and Nine Months 2012 Financial Results
2. IntelliCell BioSciences Announces It Will Present and Run Workshop at the 10th Annual Commercialization of Regenerative Medicine in London
3. Egenix, Inc. Announces New Director, John Reid
4. The Trendlines Group Announces Co-development Agreement with Endo
5. BioLife Solutions Announces 2012 Third Quarter Results: Ninth Straight Quarter of Record Revenue
6. Sapio Sciences Announces Exemplar LIMS for Tablet Computers
7. SomaGenics Announces Issue of Key Patent for Its sshRNA Technology and Receipt of Two New Small Business Innovation NIH Grants
8. Karyopharm Therapeutics Announces Oral Presentation at the American College of Rheumatology (ACR) on the use of Selective Inhibitors of Nuclear Export (SINE) CRM1 Antagonists in preclinical models of Systemic Lupus Erythematosus (SLE)
9. AstraZeneca Announces Top-line Phase III Results from Naloxegol Pivotal Trials In Patients With Opioid-Induced Constipation
10. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
11. Apexigen Announces Initiation of Clinical Trials By Its Partner, Simcere Pharmaceutical Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... Poway, California (PRWEB) , ... October 10, 2017 , ... ... afternoon speaking at his local San Diego Rotary Club. The event ... San Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined ...
(Date:10/10/2017)... ... 2017 , ... The Pittcon Program Committee is pleased to ... who have made outstanding contributions to analytical chemistry and applied spectroscopy. Each award ... conference and exposition for laboratory science, which will be held February 26-March 1, ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree Wellness Center ... the needs of consumers who are incorporating medical marijuana into their wellness and ... , As operators of two successful Valley dispensaries, The Giving Tree’s two founders, ...
Breaking Biology Technology:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
Breaking Biology News(10 mins):